Aster DM Healthcare Limited (ASTERDM.NS)
INR 492.7
(-0.46%)
INR 492.7
(-0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.29 Billion INR | -69.57% |
| 2022 | 4.24 Billion INR | -19.22% |
| 2021 | 5.25 Billion INR | 256.02% |
| 2020 | 1.47 Billion INR | -46.59% |
| 2019 | 2.76 Billion INR | -16.96% |
| 2018 | 3.33 Billion INR | 23.89% |
| 2017 | 2.68 Billion INR | 35.32% |
| 2016 | 1.98 Billion INR | 436.69% |
| 2015 | -590.15 Million INR | -144.48% |
| 2014 | 1.32 Billion INR | -25.36% |
| 2013 | 1.77 Billion INR | 93.7% |
| 2012 | 917.81 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 51.45 Billion INR | 21511.49% |
| 2024 Q2 | 968.4 Million INR | -98.12% |
| 2023 Q2 | -307.9 Million INR | -728.37% |
| 2023 Q3 | 1.79 Billion INR | 682.04% |
| 2023 Q4 | -240.3 Million INR | -113.41% |
| 2023 FY | 1.29 Billion INR | -69.57% |
| 2023 Q1 | 49 Million INR | -97.13% |
| 2022 Q1 | 695.4 Million INR | -69.27% |
| 2022 Q2 | 462.1 Million INR | -33.55% |
| 2022 Q3 | 1.39 Billion INR | 201.64% |
| 2022 FY | 4.24 Billion INR | -19.22% |
| 2022 Q4 | 1.7 Billion INR | 22.51% |
| 2021 FY | 5.25 Billion INR | 256.02% |
| 2021 Q4 | 2.26 Billion INR | 52.53% |
| 2021 Q3 | 1.48 Billion INR | 38.75% |
| 2021 Q2 | 1.06 Billion INR | 140.41% |
| 2021 Q1 | 444.7 Million INR | -57.8% |
| 2020 Q3 | 924.2 Million INR | 181.25% |
| 2020 Q2 | 328.6 Million INR | 139.62% |
| 2020 Q1 | -829.3 Million INR | -163.25% |
| 2020 FY | 1.47 Billion INR | -46.59% |
| 2020 Q4 | 1.05 Billion INR | 14.03% |
| 2019 Q3 | 1.39 Billion INR | 4358.97% |
| 2019 Q2 | 31.2 Million INR | -4.29% |
| 2019 FY | 2.76 Billion INR | -16.96% |
| 2019 Q1 | 32.6 Million INR | -98.44% |
| 2019 Q4 | 1.31 Billion INR | -5.76% |
| 2018 Q1 | 124 Million INR | -93.48% |
| 2018 FY | 3.33 Billion INR | 23.89% |
| 2018 Q4 | 2.09 Billion INR | 108.62% |
| 2018 Q3 | 1 Billion INR | 808.88% |
| 2018 Q2 | 110.4 Million INR | -10.97% |
| 2017 Q3 | 1.55 Billion INR | 30321.57% |
| 2017 Q1 | -769.3 Million INR | 0.0% |
| 2017 FY | 2.68 Billion INR | 35.32% |
| 2017 Q4 | 1.9 Billion INR | 22.55% |
| 2017 Q2 | 5.1 Million INR | 100.66% |
| 2016 FY | 1.98 Billion INR | 436.69% |
| 2015 FY | -590.15 Million INR | -144.48% |
| 2014 FY | 1.32 Billion INR | -25.36% |
| 2013 FY | 1.77 Billion INR | 93.7% |
| 2012 FY | 917.81 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 8.98 Billion INR | 85.613% |
| Artemis Medicare Services Limited | 491.4 Million INR | -163.082% |
| Fortis Healthcare Limited | 5.98 Billion INR | 78.413% |
| HealthCare Global Enterprises Limited | 481.55 Million INR | -168.466% |
| Indraprastha Medical Corporation Limited | 1.23 Billion INR | -4.292% |
| Krishna Institute of Medical Sciences Limited | 3.1 Billion INR | 58.317% |
| Lotus Eye Hospital and Institute Limited | 29.14 Million INR | -4335.752% |
| Max Healthcare Institute Limited | 10.57 Billion INR | 87.777% |
| Max India Limited | -563.76 Million INR | 329.315% |
| Global Health Limited | 4.78 Billion INR | 72.965% |
| Narayana Hrudayalaya Limited | 7.89 Billion INR | 83.62% |
| Rainbow Children's Medicare Limited | 2.17 Billion INR | 40.424% |
| Shalby Limited | 840.77 Million INR | -53.764% |